Choose another ingredient

THE INGREDIENT LIBRARY · Entry 581

Bitter melon fruit-pulp powder

Dried seedless bitter melon pulp, powder and capsules beside a closed jar
Decorative illustration of dried, seed-removed bitter melon fruit pulp and generic oral powder capsules; not a preparation or identification reference.

At a glance

Bitter melon fruit-pulp powder has limited short-term glucose research. The studied capsule was not cooked bitter melon, vine tea or an equivalent to metformin.

Key cautions

  • Do not replace diabetes drugs; discuss low-glucose risk and avoid unsupervised concentrated use.
Read the full cautions

What’s inside

The studied pulp powder was checked for charantin content and for contamination. A named marker does not establish all active ingredients or equal products.

Uses in brief

  • Supportive care: A short trial found a modest glucose-marker effect, smaller than metformin.

History, folklore and reported uses

History, folklore and traditional uses

The 2011 Thai trial used authenticated, tested fruit pulp in capsules. Its authors describe earlier diabetes use, but the four-week study does not validate every traditional preparation.

Traditional, historical and reported uses

  1. Glucose-marker research
    Human researchWhy this label?

    Reported use or research history, with the form and evidentiary limits stated in the entry. This label is not a treatment endorsement.

    The highest tested powder group improved fructosamine from baseline, less than metformin. That short active-control trial cannot establish durable diabetes control or equal treatment efficacy.

Only documented uses and research history are included. Modern study products do not inherit ancient clinical evidence.

Story sources

Health topics: evidence and cautions

These notes describe a specific research context and preparation. A topic link is not a treatment recommendation.

Diabetes and prediabetes · Support during care

Form and route: Trial-style oral powder capsules · oral

A short trial found a modest glucose-marker effect, smaller than metformin.

Evidence: small_short_randomized_trial

The four-week active-control trial measured fructosamine; the highest tested powder group improved from baseline.

Limits

This does not establish equal efficacy to metformin, durable HbA1c benefit, or effects from cooked fruit or vine tea.

Cautions

  • Do not replace diabetes drugs; discuss low-glucose risk and avoid unsupervised concentrated use.

Read the full Diabetes and prediabetes topic record

Identity & detailed reference

Identity

Dried powder of unripe Momordica charantia fruit pulp with seeds removed, in oral capsules. This excludes vine, seed, cooked vegetable and mixed extracts.

Ingredient details, preparation and research

Source plant or material

Momordica charantia

Plant family / material: Cucurbitaceae (gourd family)

Forms and route

Trial-style oral powder capsules. Oral route only unless a historical context is expressly separated.

Vitamins and minerals

No universal serving values apply to this formulation. A constituent being present does not establish nutritional adequacy or clinical benefit.

Traditional and reported uses

  • A short trial found a modest glucose-marker effect, smaller than metformin.

Contraindications and cautions

  • Do not replace diabetes drugs; discuss low-glucose risk and avoid unsupervised concentrated use.
  • The trial excluded pregnancy, lactation and significant kidney or liver abnormalities; it cannot establish safety in these groups.

Similar items and how they compare

  • Bitter melon food (247); vine (555)

    Common plant origin.

    Seed-free dried unripe pulp capsules are distinct from cooked fruit or vine preparations.

Identity and composition

Dried powder of unripe Momordica charantia fruit pulp with seeds removed, in oral capsules. This excludes vine, seed, cooked vegetable and mixed extracts. The studied pulp powder was checked for charantin content and for contamination. A named marker does not establish all active ingredients or equal products.

What the human evidence can show

The four-week active-control trial measured fructosamine; the highest tested powder group improved from baseline. This does not establish equal efficacy to metformin, durable HbA1c benefit, or effects from cooked fruit or vine tea.

Safety and limits

Do not replace diabetes drugs; discuss low-glucose risk and avoid unsupervised concentrated use. The trial excluded pregnancy, lactation and significant kidney or liver abnormalities; it cannot establish safety in these groups.

Evidence limits

  • This does not establish equal efficacy to metformin, durable HbA1c benefit, or effects from cooked fruit or vine tea.
  • A product-specific result cannot establish every commercial preparation.

Entry sources